Roadmaps for your arthritis

Practical tools for inflammatory arthritis

Arthritis Australia has worked with The Targeted Therapies Alliance to develop information and resources for consumers, including practical tools and roadmaps for people with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.


Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (including axial spondyloarthritis and non-radiographic axial spondyloarthritis) are lifelong conditions. With treatment and support, life can be positive, meaningful and healthy. These roadmap will help you understand how to manage your arthritis, including self-management techniques and the use of medicines. It will also help you prepare for follow-up appointments with your healthcare team.

Your roadmap for rheumatoid arthritis

Your roadmap for psoriatic arthritis

Your roadmap for ankylosing spondylitis

Action Plans

Low-dose methotrexate action plan

Use this action plan to discuss methotrexate with your rheumatologist and plan the best way to take your medicine.

Managing your flares action plan

This action plan is for people with inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis (also called axial spondyloarthritis). Use this action plan to discuss and plan the best way to manage flares with your rheumatology team.

Decision aids and Factsheets

Patient decision aid: My rheumatoid arthritis is under control – what should I do about my medicine? 

Taking a biological or targeted medicine has helped you to control your rheumatoid arthritis. This guide can help you decide whether to reduce or continue taking the same amount of your medicine, and what questions to ask your rheumatologist.

Fact sheet: My rheumatoid arthritis is well controlled with a biological or targeted medicine: can I take less medicine? 

Your rheumatoid arthritis (RA) is now well controlled with a biological or targeted medicine, so it may be possible to reduce the amount of medicine you take. Find out more about why reducing the amount of medicine you take might be possible, the potential benefits and harms, and things to discuss with your rheumatologist before making your decision.

To see all the information and resources, visit the Rheumatology conditions for consumers page on the NPS MedicineWise website.


These resources have been developed with NPS MedicineWise and seven other organisations representing specialists, pharmacists, consumers and research experts, which form the Targeted Therapies Alliance. The Alliance provides stewardship and direction about the safe and wise use of biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines. Additional inflammatory arthritis resources for consumers can be found here: reviewed October 2022.